- Leerink Partners sets a price target of $119 for Medtronic, Inc. (NYSE:MDT), indicating a potential upside of 31.78%.
- Medtronic acquires Scientia Vascular for $550 million to enhance its Neurovascular portfolio.
- The stock’s trading volume reflects active investor interest, with a market capitalization of approximately $115.82 billion.
Medtronic, Inc. (NYSE:MDT) is a global leader in medical technology, services, and solutions. The company focuses on improving healthcare by providing innovative products and therapies. Medtronic operates in various segments, including Cardiac and Vascular, Minimally Invasive Therapies, Restorative Therapies, and Diabetes. It competes with other major players like Boston Scientific and Abbott Laboratories.
On March 10, 2026, Mike Kratky from Leerink Partners set a price target of $119 for MDT, which was trading at $90.31 at the time. This suggests a potential upside of 31.78%. Leerink Partners reiterated their “Outperform” rating, emphasizing an acquisition as an “incremental positive” for Medtronic. The stock’s current price is $90.54, reflecting a slight decrease of 0.88%.
Medtronic’s acquisition of Scientia Vascular, valued at $550 million, is a strategic move to enhance its Neurovascular portfolio. Scientia Vascular, based in Salt Lake City, Utah, is known for its innovative technology in the neurovascular sector. This acquisition aims to integrate Scientia’s advanced access products, crucial for treating complex neurovascular conditions.
The acquisition aligns with Medtronic’s mission to support healthcare professionals in critical situations. Scientia Vascular employs approximately 310 people and is led by founder and Chief Technology Officer John Lippert. The deal includes potential additional earn-out and milestone payments, further strengthening Medtronic’s position in the market.
Medtronic’s stock has traded between $89.15 and $91.41 today, with a market capitalization of approximately $115.82 billion. Over the past year, MDT reached a high of $106.33 and a low of $79.55. Today’s trading volume is 3,985,017 shares, indicating active investor interest in the company’s future prospects.
